Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMirallas Viñas, Oriol
dc.contributor.authorFilippi Arriaga, Maria Francesca Eugenia
dc.contributor.authorHernández Hernández, Irene
dc.contributor.authorAubanell, Anton
dc.contributor.authorChaachou, Anas
dc.contributor.authorGarcia-Alvarez, Alejandro
dc.contributor.authorHernando Cubero, Jorge
dc.contributor.authorMartinez Saez, Elena Antima
dc.contributor.authorBiagetti Biagetti, Betina
dc.contributor.authorCapdevila Castillon, Jaume
dc.date.accessioned2022-06-02T08:33:20Z
dc.date.available2022-06-02T08:33:20Z
dc.date.issued2021-11-11
dc.identifier.citationMirallas O, Filippi-Arriaga F, Hernandez Hernandez I, Aubanell A, Chaachou A, Garcia-Alvarez A, et al. Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report. Front Endocrinol. 2021 Nov 11;12:731631.
dc.identifier.issn1664-2392
dc.identifier.urihttps://hdl.handle.net/11351/7615
dc.descriptionTumors hipofisaris agressius; Capecitabina; Temozolomida
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Endocrinology;12
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectAdenoma - Tractament
dc.subjectHipòfisi - Tumors - Tractament
dc.subjectQuimioteràpia combinada
dc.subject.meshNelson Syndrome
dc.subject.mesh/drug therapy
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshAdenoma
dc.titleAggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fendo.2021.731631
dc.subject.decssíndrome de Nelson
dc.subject.decs/farmacoterapia
dc.subject.decsprotocolos de quimioterapia antineoplásica combinada
dc.subject.decsadenoma
dc.relation.publishversionhttps://doi.org/10.3389/fendo.2021.731631
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Mirallas O, Garcia-Alvarez A, Hernando J, Capdevila J] Servei d’Oncologia Mèdica, Unitat de Tumors Gastrointestinals i Endocrins, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Filippi-Arriaga F] Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Hernandez Hernandez I, Biagetti B] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Aubanell A] Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Chaachou A, Martínez-Saez E] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid34858324
dc.identifier.wos000727887300001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple